NBP — NovaBridge Biosciences
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2020-01-17.
Performance
Technicals
Others in Healthcare
Measured signals that fired on NBP
| date | signal | measured base rate |
|---|---|---|
| 2026-06-02 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-04-29 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
| 2026-04-28 | Conviction buy by an officer insider | -1.03% over 21 days · t = -2.24 · n = 1,083 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-06 | Xu Cong Claire SVP, Clinical Development | Open-market sale | 4.5K | 0.89 | 4.0K |
| 2026-07-04 | Xu Cong Claire SVP, Clinical Development | Option exercise | 12.4K | — | — |
| 2026-06-18 | Dennis Phillip Andrew Chief Medical Officer | Open-market sale | 8.5K | 0.66 | 5.6K |
| 2026-06-17 | Dennis Phillip Andrew Chief Medical Officer | Option exercise | 23.7K | — | — |
| 2026-06-01 | Xu Cong Claire SVP, Clinical Development | Open-market sale | 3.5K | 3.94 | 13.8K |
| 2026-05-30 | Xu Cong Claire SVP, Clinical Development | Option exercise | 9.4K | — | — |
| 2026-05-14 | Cao Sean Wuxiong See Remarks | Open-market sale | 21.4K | 1.99 | 42.6K |
| 2026-04-24 | Hagler Mark Arnold See Remarks | Open-market purchase | 230.0K | 2.51 | 577.3K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 14.8M | 6.0M |
| HHLR ADVISORS, LTD. | 14.7M | 6.0M |
| MORGAN STANLEY | 9.4M | 3.8M |
| Siren, L.L.C. | 7.4M | 3.0M |
| AIHC Capital Management Ltd | 5.6M | 2.3M |
| Point72 Asset Management, L.P. | 3.4M | 1.4M |
| Candriam S.C.A. | 2.8M | 1.1M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.5M | 1.0M |
| Woodline Partners LP | 1.7M | 700.0K |
| BlackRock, Inc. | 1.5M | 627.5K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 6-K | 2026-08-20 | 2026-06-30 | on EDGAR ↗ |
| 6-K | 2026-08-20 | 2026-08-20 | on EDGAR ↗ |
| S-8 | 2026-08-17 | — | on EDGAR ↗ |
| 6-K | 2026-07-24 | 2026-07-24 | on EDGAR ↗ |
| 6-K | 2026-07-17 | 2026-07-13 | on EDGAR ↗ |
| 4 | 2026-07-10 | 2026-07-08 | on EDGAR ↗ |
| 4 | 2026-07-10 | 2026-07-08 | on EDGAR ↗ |
| 4 | 2026-07-08 | 2026-07-06 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- NovaBridge Biosciences (NBP) filed form 6-K · 2026-08-20 · SEC EDGAR
- NovaBridge Biosciences (NBP) filed form 6-K · 2026-08-20 · SEC EDGAR
Ask the AI about NBP
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →